Clinical-stage biopharma company developing targeted therapies for cancer and other serious diseases using degraders, inhibitors, and ADCs.
Get notified the moment Treeline Biosciences files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.